About Index Trending news
Analyze
Top 50 Pricing
Galectin Therapeutics

Galectin Therapeutics

Work at Galectin Therapeutics? Add yourself to this profile

Galectin Therapeutics

Galectin Therapeutics Inc (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins

Elsewhere

Twitter followers

Latest funding
Grant
$489,000
Venture capital (Series B)
$1,800,000
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Galectin Therapeutics makes some noise.